Dulac Edward J III 4
4 · FATE THERAPEUTICS INC · Filed Mar 5, 2024
Insider Transaction Report
Form 4
Dulac Edward J III
Chief Financial Officer
Transactions
- Sale
Common Stock
2024-03-04$7.77/sh−2,447$19,013→ 101,479 total
Footnotes (1)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 5, 2023.